AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17873675
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg at 6-month follow-up
Trial: 17873675
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg at 12 weeks
Trial: 15738918
Drug: Reconstruction of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reconstruction of three-dimensional dose distributions from two-dimensional treatment plan information
Trial: 9176441
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II immunoreactivity in ascites from pregnant OHSS (1,669 ± 418 pg/mL)
Trial: 31774002
Drug: Transcutaneous electrical
RxNorm normalized name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrical nerve stimulation (TENS) combined with oral lactulose solution
Trial: 31774002
Drug: Oral lactulose
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral lactulose solution
Trial: 27495097
Drug: Home-based exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based exercise training program (cycling 3 times weekly for 35 minutes for 24 weeks)
Trial: 22240839
Drug: Gabapentin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (200 mg) alone
Trial: 22240839
Drug: Gabapentin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (200 mg) + 1 g magnesium oxide (MgO)
Trial: 22240839
Drug: Gabapentin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (200 mg) + 20 mg omeprazole
Trial: 20017166
Drug: Conventional-dose radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional-dose radiotherapy (<74 Gy) with hormonal therapy
Trial: 20017166
Drug: Escalated-dose radiotherapy
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalated-dose radiotherapy (≥74 Gy) with hormonal therapy
Trial: 20017166
Drug: Moderately escalated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately escalated dose (74 Gy) with hormonal therapy
Trial: 20017166
Drug: High escalated
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High escalated dose (≥78 Gy) with hormonal therapy
Trial: 18664024
Drug: Acute normovolaemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute normovolaemic haemodilution (ANH) with crystalloids (saline solution)
Trial: 8707264
Drug: Tapering interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering interferon (IFN) dose (3 mu, 2 mU, 1 mU, and 0.5 mU three times a week, then 0.5 mU twice weekly and once weekly)
Trial: 8707264
Drug: Stopping interferon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopping interferon (IFN) treatment
Trial: 8707264
Drug: Tapering interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering interferon (IFN) dose
Trial: 8452178
Drug: fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fleroxacin 400 mg for 1 day
Trial: 8452178
Drug: fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fleroxacin 400 mg daily for 2 days
Trial: 3006449
Drug: Captopril 150
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril 150 mg
Trial: 19592202
Drug: Computer-assisted insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Computer-assisted insulin protocol (CAIP)
Trial: 15118193
Drug: Reconstituted fruit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reconstituted fruit juice (FJ, 10.4% total carbohydrate, 489 mosmol/L, pH= 3.2)
Trial: 15118193
Drug: Flavored water
RxNorm normalized name: FLAVOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavored water (FW, no carbohydrate, osmolality = 48 mosmol/L, pH = 3.3)
Trial: 15118193
Drug: Sports drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sports drink (SD, 6% total carbohydrate, 295 mosmol/L, pH = 3.3)
Trial: 11172512
Drug: Intrathecal hyperbaric
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal hyperbaric bupivacaine 3.75 mg with fentanyl 25 microg
Trial: 11172512
Drug: Hyperbaric lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperbaric lidocaine 30 mg with fentanyl 25 microg
Trial: 3578568
Drug: Paraprofessional drug
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paraprofessional drug counseling
Trial: 30562785
Drug: Intranasal placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal placebo (0.9% saline) 0.02 mL/kg
Trial: 22414688
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice (BJ) 0, 100, 250, and 500 g
Trial: 22414688
Drug: Red beetroot-enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red beetroot-enriched bread (100 g)
Trial: 22414688
Drug: Control bread
RxNorm normalized name: Eazi-Breed CIDR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control bread (0 g beetroot)
Trial: 21079163
Drug: Buffered preservative‐free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered preservative‐free acidified solution in saline nasal spray
Trial: 21079163
Drug: Benzalkonium chloride‐containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzalkonium chloride‐containing saline nasal spray
Trial: 21079163
Drug: Both nasal
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both nasal spray solutions
Trial: 12847284
Drug: Live recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live recombinant canarypox ALVAC-HIV vaccine with or without rgp120/SF-2
Trial: 10439770
Drug: Granisetron 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 2.5 mg
Trial: 8537681
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 10(7) TCID50 of live, attenuated cold‐adapted influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine
Trial: 8537681
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 10(7) TCID50 of ca influenza virus
Trial: 1925862
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment followed by radiation therapy (102 patients), total dose of 45 to 55 Grays delivered to specific areas.
Trial: 1925862
Drug: Isolated surgical
RxNorm normalized name: ISOLATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isolated surgical treatment (119 patients).
Trial: 1925862
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment followed by radiation therapy (102 patients).
Trial: 6958488
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 micrograms daily for 4 months
Trial: 22252927
Drug: Acupuncture-like transcutaneous
RxNorm normalized name: insulin-like growth factor 2
DrugBank: Insulin-like growth factor II (DB14472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture-like transcutaneous electrical nerve stimulation (ALTENS) - 24 sessions over 12 weeks, twice weekly.
Trial: 19463151
Drug: HX575 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HX575 (100 IU/kg body weight, intravenous, three-times-weekly for four weeks)
Trial: 19463151
Drug: Comparator epoetin
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator epoetin alfa (100 IU/kg body weight, intravenous, three-times-weekly for four weeks)
Trial: 9795453
Drug: 90-ml oral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 90-ml oral sodium phosphate (NaP)
Trial: 9795453
Drug: 45-ml oral
RxNorm normalized name: PROSOURCE TF LIQUID,ORAL,45ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45-ml oral sodium phosphate (NaP)
Trial: 7709404
Drug: Picotamide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picotamide (300 mg TID)
Trial: 2796621
Drug: Aminophylline 2
RxNorm normalized name: aminophylline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline 2 mg/kg iv
Trial: 2796621
Drug: Physostigmine 1
RxNorm normalized name: PHYSostigmine 1 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine 1 mg iv and naloxone 0.4 mg im
Trial: 66567
Drug: Metiamide (nocturnal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metiamide (nocturnal administration)
Trial: 66567
Drug: Metiamide (continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metiamide (continued administration for 1 year)
Trial: 66567
Drug: Metiamide (cessation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metiamide (cessation of treatment)
Trial: 31475495
Drug: Medication (Climen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Climen, 1 tablet/d for 21 days)
Trial: 31475495
Drug: Acupuncture (manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (manual stimulation of specific points from day 8 to 15 of menstruation, once daily for 3 cycles)
Trial: 31475495
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (acupuncture + medication)
Trial: 31475495
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment vs Acupuncture
Trial: 31475495
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment vs Medication
Trial: 31475495
Drug: Acupuncture vs
RxNorm normalized name: VS-4718
DrugBank: VS-4718 (DB15273)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture vs Medication
Trial: 21672493
Drug: ziprasidone, 20‐80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ziprasidone, 20‐80 mg twice a day
Trial: 21672493
Drug: placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo twice a day
Trial: 18636953
Drug: Parenteral MenB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral MenB outer membrane vesicle vaccine
Trial: 1419223
Drug: Astemizole 5
RxNorm normalized name: astemizole 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole 5 mg daily for 2 weeks followed by increasing doses (5, 10, 20, 40 mg per day)
Trial: 1419223
Drug: Astemizole 10
RxNorm normalized name: astemizole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole 10 mg daily for 12 weeks
Trial: 30643081
Drug: Proton Pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton Pump Inhibitor (PPI) - esomeprazole
Trial: 30643081
Drug: Histamine H2
RxNorm normalized name: Histamine H2 receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine H2 receptor antagonist (H2 blocker) - famotidine
Trial: 20077670
Drug: Domestic split
RxNorm normalized name: domestic cow dander extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domestic split influenza virus vaccine
Trial: 20077670
Drug: Imported split
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imported split influenza virus vaccine
Trial: 17341027
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg flucloxacillin capsules
Trial: 7761016
Drug: Total Intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Intravenous Anaesthesia (TIVA): propofol + fentanyl + pancuronio bromide
Trial: 3260794
Drug: Magnesium chloride
RxNorm normalized name: Magnesium Chloride
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium chloride 16 mmol in 10 ml of water
Trial: 3260794
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of water alone (control group)
Trial: 31928690
Drug: Alpelisib in
RxNorm normalized name: Product containing alpelisib in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpelisib in combination with fulvestrant
Trial: 29878340
Drug: Erenumab 140
RxNorm normalized name: Erenumab 140 mg/mL solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erenumab 140 mg IV infusion
Trial: 28157100
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg for 6 weeks and 10 mg for 18 weeks)
Trial: 9434648
Drug: Reduced-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced-fat diet (ad libitum) with dietary assessment and education followed by monthly meetings to reduce fat intake (months 1-6)
Trial: 2574958
Drug: Amitriptyline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (75 mg/day) and distigmine (10 mg/day)
Trial: 2574958
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of distigmine to preexisting amitriptyline treatment
Trial: 1139387
Drug: Atropine 0.4
RxNorm normalized name: atropine 0.4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 0.4 mg
Trial: 1139387
Drug: Atropine (intravenous)
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine (intravenous)
Trial: 1139387
Drug: Glycopyrrolate (intramuscular)
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (intramuscular)
Trial: 23992557
Drug: Colchicine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (0.5 mg twice daily for patients >70 kg or 0.5 mg once daily for patients ≤70 kg)
Trial: 18679038
Drug: Responder group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Responder group (depressive patients responding to treatment)
Trial: 18679038
Drug: Unresponsive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unresponsive group (depressive patients not responding to treatment)
Trial: 16544257
Drug: Combination therapies
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapies (specific types not detailed)
Trial: 16544257
Drug: Intermittent presumptive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent presumptive therapy, improved case management, and reduction in transmission intensity
Trial: 15230074
Drug: Opioid agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid agonist treatment (n = 203)
Trial: 15230074
Drug: Medication-free treatment
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Head & Shoulders Damage Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-free treatment (n = 155)
Trial: 11473971
Drug: Lofexidine hydrochloride
RxNorm normalized name: LOFEXIDINE HYDROCHLORIDE
DrugBank: Lofexidine (DB04948)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lofexidine hydrochloride (up to 600 mg twice daily over 8 weeks)
Trial: 2600210
Drug: TRUE Test
RxNorm normalized name: SunMark True Test Strips
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRUE Test patch test system
Trial: 30372440
Drug: Cash-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cash-based intervention (CBI) - monthly unconditional cash transfer of US$84.00 for 5 months, non-food-items kit distribution, provision of piped water free of charge.
Trial: 27560540
Drug: Guanidinoacetic acid
RxNorm normalized name: Guanidinoacetic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanidinoacetic acid (GAA) 3.0 g/day
Trial: 20467188
Drug: Pioglitazone 30
RxNorm normalized name: pioglitazone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 30 mg/day for 16 weeks
Trial: 1657527
Drug: Argon laser
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon laser trabeculoplasty (ALT) followed by medical treatment if needed to control intraocular pressure (IOP)
Trial: 7204470
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment on a Thomas' splint
Trial: 31088302
Drug: Extended thromboprophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended thromboprophylaxis with oral anticoagulation
Trial: 18496372
Drug: Intravenous alanyl‐glutamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous alanyl‐glutamine supplementation (0.3 g/kg x day(‐1) from day 4 until day 17) and intravenous growth hormone (50 microg/kg x day(‐1) from day 10 onward)
Trial: 10920133
Drug: PEG‐rHuMGDF administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐rHuMGDF administered subcutaneously after chemotherapy
Trial: 10920133
Drug: PEG‐rHuMGDF administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐rHuMGDF administered before chemotherapy
Trial: 10920133
Drug: PEG‐rHuMGDF administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐rHuMGDF administered after chemotherapy
Trial: 10920133
Drug: PEG‐rHuMGDF administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐rHuMGDF administered alone
Trial: 1637696
Drug: etretinate TL-01
RxNorm normalized name: etretinate
DrugBank: Etretinate (DB00926)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: etretinate TL-01 combination therapy (re-TL-01)
Trial: 3931143
Drug: IV doses
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV doses (0.2, 0.4, or 0.6 mg/kg)
Trial: 3931143
Drug: Oral doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral doses (2, 3, or 4 mg/kg)
Trial: 29409833
Drug: Algorithm for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Algorithm for abortion intravenous sedation dosing (AAID)
Trial: 26349796
Drug: Three-in-one injection
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-in-one injection comfort system (ICS)
Trial: 26349796
Drug: 10 percent
RxNorm normalized name: BENZOYL PEROXIDE 10 g in 100 mL TOPICAL LOTION [SMART RELEASE BPO 10 PERCENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 percent lidocaine pump spray
Trial: 11554235
Drug: Tropisetron (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron (0.2 mg/kg/24 h intravenously)
Trial: 9692122
Drug: Nasal beclomethasone
RxNorm normalized name: beclomethasone Nasal Spray
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal beclomethasone dipropionate (BDP) 400 micrograms daily
Trial: 9692122
Drug: Nasal anti-histamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal anti-histamine levocabastine 200 micrograms daily
Trial: 3168450
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Mifepristone
Trial: 30075886
Drug: Carvacrol (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvacrol (1.2 mg/kg/day) for two months
Trial: 16624147
Drug: nCPAP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nCPAP therapy in OSAHS group
Trial: 16624147
Drug: nCPAP therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nCPAP therapy in OSAHS with CHD group
Trial: 27163518
Drug: Vaginal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal estrogen (VE) therapy, 0.5g promestriene cream twice a week for 6 weeks before surgery
Trial: 27163518
Drug: Non-vaginal estrogen
RxNorm normalized name: estrogens, conjugated (USP) Vaginal Cream [Premarin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-vaginal estrogen (non-VE) therapy, no pharmacologic preparation before surgery
Trial: 22567139
Drug: Syrups of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrups of combination ART including Nevirapine, Zidovudine, Abacavir and Lamivudine
Trial: 22567139
Drug: Scored adult-dose
RxNorm normalized name: hepatitis A vaccine (inactivated) strain HM175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scored adult-dose tablets prescribed according to WHO weightband tables
Trial: 22567139
Drug: Syrups
RxNorm normalized name: Syrups, hydrolyzed starch, dehydrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrups
Trial: 19673898
Drug: subcutaneous sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: subcutaneous sumatriptan 6 mg
Trial: 6973990
Drug: Fluproquazone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluproquazone (200 mg)
Trial: 6973990
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) (1000 mg)
Trial: 31227028
Drug: Vildagliptin 100
RxNorm normalized name: vildagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 100 or 50 mg/day for 2 months
Trial: 20456070
Drug: Standard multimodal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard multimodal inpatient treatment
Trial: 2182423
Drug: Sequential decision
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential decision strategy